Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
26.6M
-
Shares change
-
+445K
-
Total reported value, excl. options
-
$794M
-
Value change
-
+$16.3M
-
Put/Call ratio
-
1.35
-
Number of buys
-
65
-
Number of sells
-
-52
-
Price
-
$29.79
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q2 2014
162 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2014.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.6M shares
of 106M outstanding shares and own 25.22% of the company stock.
Largest 10 shareholders include LORD, ABBETT & CO. LLC (3.07M shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (2.63M shares), PERCEPTIVE ADVISORS LLC (2.56M shares), VANGUARD GROUP INC (2.23M shares), BlackRock Fund Advisors (1.39M shares), D. E. Shaw & Co., Inc. (1.32M shares), FMR LLC (1.26M shares), State Street Corp (1.08M shares), BlackRock Institutional Trust Company, N.A. (1.07M shares), and GILDER GAGNON HOWE & CO LLC (845K shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.